Navigation Links
Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
Date:10/22/2007

TAXUS IV study demonstrates long-term safety and efficacy of TAXUS drug-

eluting stent compared to bare-metal stent

NATICK, Mass., and WASHINGTON, Oct. 22 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced five-year and final follow- up data from its TAXUS IV clinical trial. The benefits previously reported at years one through four -- in patients who received a TAXUS(R) Express(TM) Paclitaxel-Eluting Coronary Stent compared to patients who received a bare- metal stent (BMS) -- were maintained at five years. Stephen G. Ellis, M.D., the trial's Co-Principal Investigator and Director of the Cleveland Clinic's Sones Cardiac Catheterization Laboratories, presented the TAXUS IV five-year results at the annual Transcatheter Cardiovascular Therapeutics (TCT) symposium in Washington, D.C.

"The five-year TAXUS IV follow-up study of the TAXUS Express Stent clearly demonstrates long-term safety, with similar rates of death, myocardial infarction, and stent thrombosis across a broad cross section of patients and lesions and with no new cases of stent thrombosis between years four and five," said Gregg W. Stone, M.D., of Columbia University Medical Center and the Cardiovascular Research Foundation, New York, the Principal Investigator for the TAXUS IV clinical trial. "The TAXUS IV data combined with the TAXUS II results presented in September clearly add to the growing body of evidence reinforcing the long-term safety of TAXUS paclitaxel-eluting stents."

The results of TAXUS IV reaffirm the long-term safety of the TAXUS Stent as demonstrated by an excellent five-year safety profile. Rates of all death (10.0% vs. 11.2%, p=0.49), cardiac death (4.4% vs. 4.5%, p=0.85
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015  In today,s ever-changing marketplace, call centers ... mobile, increasingly connected, and increasingly impatient with slow service. ... interaction channels and tools is driving call centers to ... According to research by benchmarking firm, Best ... segment in a call center study realize the impact ...
(Date:7/31/2015)... 31, 2015 More than 1,500 substance abuse ... convene in Indianapolis Aug. 2-6 ... Mid-Year Training Institute . The week-long training, held at ... one of our nation,s biggest public health challenges – ... Institute is a one-of-a-kind intensive training opportunity, offering more ...
(Date:7/31/2015)... RnRMarketResearch.com adds Syringes and ... that provides an overview of syringes and needles ... in-house databases, secondary and primary research. ... pipeline spread across 124 pages, talking about 13 ... 5 figures is now available at http://www.rnrmarketresearch.com/syringes-and-needles-pipeline-review-2015-market-report.html ...
Breaking Medicine Technology:Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 2Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5
... July 28, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: ... developer, manufacturer and marketer of orthopedic implants in China, today ... financial results on August 16, 2011, before the market opens. ... a.m. ET on August 16, 2011 to discuss second quarter ...
... Soligenix, Inc. (Soligenix or the Company) (OTC BB: ... amendment of its North American licensing partnership with Sigma ... development and commercialization of orBec® (oral beclomethasone dipropionate or ... part of the amended agreement, Sigma - Tau has ...
Cached Medicine Technology:China Kanghui Holdings to Report Second Quarter 2011 Financial Results on August 16, 2011 2Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe 2Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe 3Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe 4Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe 5Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe 6Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe 7Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe 8
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... Health notes that while an overwhelming number of Hispanics believe people can ... The overwhelming 70 percent of participants queried said making diet changes was important. ...
(Date:8/3/2015)... (PRWEB) , ... August 03, ... ... bodybuilding and fitness site and the largest online retailer of nutritional supplements, ... BPI Sports is up for 11 awards in the following categories:, ...
(Date:8/3/2015)... Beach, CA (PRWEB) , ... August 03, 2015 ... ... individuals suffering from ALS and amputation , AUGUST 3, 2015 – Since winning ... category in March 2015, Not Impossible – an organization whose mission is to ...
(Date:8/3/2015)... NC (PRWEB) , ... August 03, 2015 , ... The ... by experience. Learning from her grandmother’s side at a young age, Nasreen Zereshki was ... Zereshki has decided to share her cookbook Recipes from My Persian Kitchen with the ...
(Date:8/3/2015)... FL (PRWEB) , ... August 03, 2015 , ... AxoGen, ... nerve injuries, is scheduled to present at the Wedbush Healthcare Conference on Wednesday, August ... A live webcast and subsequent archived replay of the Company’s presentation may be accessed ...
Breaking Medicine News(10 mins):Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2
... 20 CHF,International has been selected as the ... Fund) new Principal Recipient (PR) for,HIV/AIDS prevention, treatment ... awarded an HIV proposal in Round 3 programming., ... years, CHF will be directly responsible for,managing Honduras, ...
... How familiar are you,with the health of your family ... festivity of the Thanksgiving holiday, taking a good look ... That,s why Acting Surgeon General Steven K. Galson, ... Family History Day.,He encourages everyone to use the occasion ...
... System Sets ... Space-Saving Standard, WARRENDALE, ... EP Mobile MR Injection System today, MEDRAD once again,addresses the ... with market-leading injector technology suited for,small spaces. (Logo: ...
... ... ... Subspecialty,Radiology (F&S) has added 31 subspecialty radiologists to support the,growing ... industry,s largest subspecialty teleradiology network. F&S,radiologists are musculoskeletal, body, cardiac, ...
... day the Los,Angeles Times reported that cancer survivors could ... care proposals, smooth,talking Mitt Romney is slated to discuss ... report, cancer survivors "could not be,sure of getting coverage ... government or job-related plan and had to seek insurance ...
... Irvine, Calif., Nov. 20 2007 Vase or face" When presented ... a vase or the faces of two people, what we observe ... brains. , In this example, whether you see faces ... since the image always stays exactly the same, said John Serences, ...
Cached Medicine News:Health News:CHF International Named Global Fund Principal Recipient in Honduras 2Health News:Acting Surgeon General Encourages Americans to Know Their Health History During Fourth Annual Family History Day 2Health News:Acting Surgeon General Encourages Americans to Know Their Health History During Fourth Annual Family History Day 3Health News:MEDRAD Mobile MR Injector Meets Challenges of MR Trailers 2Health News:Franklin & Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 2Health News:Franklin & Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 3Health News:Franklin & Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 4Health News:Franklin & Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 5Health News:Franklin & Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 6Health News:Franklin & Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 7Health News:Franklin & Seidelmann Adds 31 Subspecialty Radiologists to Support Growing Demand for Subspecialty Expertise 8Health News:Mitt's Millions Can't Buy Iowans Health Care Reform 2Health News:Scientists uncover how the brain controls what the eyes see 2
Ideal for nucleus manipulation during phacoemulsification. Also used for manipulating and rotating IOLs within the anterior chamber. Round knurled handle...
Short, narrow paddle angled 45 degree inserts through the side port stab incision and is ideal for effective manipulation of the lens during anterior chamber phacoemulsification....
Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique. Round knurled handle. Manufactured in titanium....
#2 10 mm hook. Flat serrated handle with polished finish. Overall length: 5.5 inches....
Medicine Products: